About the Webinar
Clinical trials are becoming more complex, increasing the need for faster decisions, tighter coordination, and stronger sponsor‑site partnerships. To keep studies moving, Merck redesigned how it works with sites, adopting a relationship‑first approach centered on trust, transparency, and consistent communication. A key element of this model is Merck’s partnership with WCG, which provides targeted site support to address operational bottlenecks in enrollment, data entry, records management, and day‑to‑day workflows, balancing global consistency with local needs.
This webinar highlights how this approach scaled globally to support approximately 400 sites in more than 30 countries, helping reduce site burden and improve operational predictability.
What you’ll learn:
How implementing an integrated, relationship‑first operating model can reduce site burden and accelerate trial delivery without sacrificing human connection, including:
- How Merck evolved its sponsor‑site engagement model to manage increasing trial complexity
- How targeted site support can identify and resolve operational bottlenecks
- Why transparency helps align sponsors, CROs, and sites around shared accountability
- Lessons from scaling a consistent approach across global markets
- Practical strategies sponsors and CROs can apply to improve site experience and study momentum
Register Now
Speakers
Kate Boneck
Executive Director, U.S. Study Start Up & Innovation, Merck
Amy Thue
Associate Director, Project Management, WCG